Effects of Nonpharmacological Interventions in Sleep Quality, Anxiety, and Delirium for Patients of Adult Intensive Care Units

Launched by CHIAYI CHRISTIAN HOSPITAL · Jan 12, 2025

Keywords

ClinConnect Summary

This clinical trial is looking to understand how certain non-drug treatments can improve sleep quality, reduce anxiety, and lessen delirium in adults who are staying in Intensive Care Units (ICUs). Delirium is a sudden change in mental status, which can be confusing and distressing. The study will involve patients who are awake and able to communicate, and who have been in the ICU for more than 24 hours.

To participate in this trial, individuals must be over 18 years old, stable in their medical condition, and able to hear and respond in a quiet voice. However, those with certain conditions like severe sleep problems, a history of alcohol abuse, or significant mental health issues will not be eligible. If someone chooses to participate, they can expect to engage in activities designed to help improve their sleep and reduce anxiety during their ICU stay. The trial is not yet recruiting participants, so more information will be available soon for those interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Conscious and able to speak or write (GCS ≥ 11)
• • Hemodynamically stable
• • Normal hearing and able to communicate in a low voice
• • Stay in ICU for more than 24 hours
• • Aged over 18 years.
• Exclusion Criteria:
• • Pre-existing insomnia diagnosis with long-term reliance on sleep medication,
• • Sleep-related medical history such as sleep apnea
• • Shift work prior to hospitalization
• • Diagnosis of alcohol abuse or schizophrenia
• • End-of-life or terminal conditions
• • Allergy to essential oils
• • Exclusion of dementia